
Ac4ManNAz
CAS No. 361154-30-5
Ac4ManNAz ( —— )
Catalog No. M21882 CAS No. 361154-30-5
Ac4ManNAz is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 29 | In Stock |
![]() ![]() |
5MG | 45 | In Stock |
![]() ![]() |
10MG | 72 | In Stock |
![]() ![]() |
25MG | 160 | In Stock |
![]() ![]() |
50MG | 241 | In Stock |
![]() ![]() |
100MG | 357 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameAc4ManNAz
-
NoteResearch use only, not for human use.
-
Brief DescriptionAc4ManNAz is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
DescriptionAc4ManNAz is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPROTACs
-
TargetPROTAC
-
RecptorPEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number361154-30-5
-
Formula Weight430.37
-
Molecular FormulaC??H??N?O??
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL (232.36 mM; Need ultrasonic)
-
SMILESO=C(N[C@@H]1C(OC(C)=O)O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O)CN=[N+]=[N-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
molnova catalog



related products
-
GSK983
GSK983 (GSK-983) is a potent, cell penetrant PCAF/GCN5 PROTAC, induces concentration-dependent degradation of PCAF and GCN5 in THP1 cells with DC50 value of 1.5 nM and 3 nM, respectively.
-
Rpn13 degrader WL40
Rpn13 degrader WL40 (WL40) is a novel covalent ubiquitin receptor Rpn13 degrader by linking the Rpn13 covalent inhibitor RA190 with the cereblon (CRBN) binding ligand thalidomide.
-
BCL6 PROTAC 15
BCL6 PROTAC 15 is a novel B-cell lymphoma 6 (BCL6) PROTAC, significantly degrade BCL6 in a number of DLBCL cell lines.